129 related articles for article (PubMed ID: 21986170)
21. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.
Liao SY; Rodgers WH; Kauderer J; Bonfiglio TA; Walker JL; Darcy KM; Carter R; Hatae M; Levine L; Spirtos NM; Stanbridge EJ
Int J Cancer; 2009 Nov; 125(10):2434-40. PubMed ID: 19670419
[TBL] [Abstract][Full Text] [Related]
23. Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
Syrjänen K; Shabalova I; Naud P; Kozachenko V; Derchain S; Zakharchenko S; Roteli-Martins C; Nerovjna R; Longatto-Filho A; Kljukina L; Tatti S; Branovskaja M; Hammes LS; Branca M; Grunjberga V; Erzen M; Sarian LO; Juschenko A; Costa S; Podistov J; Syrjänen S;
Int J Gynecol Cancer; 2009 Jul; 19(5):934-42. PubMed ID: 19574788
[TBL] [Abstract][Full Text] [Related]
24. Advancing age and cervical cancer screening and prognosis.
Sawaya GF; Sung HY; Kearney KA; Miller M; Kinney W; Hiatt RA; Mandelblatt J
J Am Geriatr Soc; 2001 Nov; 49(11):1499-504. PubMed ID: 11890589
[TBL] [Abstract][Full Text] [Related]
25. Changes in the incidence of cervical tumours by disease stage in a cytology-based screening programme.
Bucchi L; Mancini S; Baldacchini F; Giuliani O; Ravaioli A; Vattiato R; Falcini F; Giorgi Rossi P; Campari C; Canuti D; Di Felice E; de Bianchi PS; Ferretti S;
J Med Screen; 2020 Jun; 27(2):96-104. PubMed ID: 31690178
[TBL] [Abstract][Full Text] [Related]
26. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
27. Liquid-based cytology and conventional cervical smears.
Melamed MR
Cancer; 2004 Jun; 102(3):200; author reply 200-1. PubMed ID: 15211480
[No Abstract] [Full Text] [Related]
28. HPV-type distribution and reproducibility of histological diagnosis in cervical neoplasia in Poland.
Nowakowski A; de Souza SC; Jach R; Rosillon D; Książek A; Holl K
Pathol Oncol Res; 2015 Jul; 21(3):703-11. PubMed ID: 25547828
[TBL] [Abstract][Full Text] [Related]
29. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.
De Strooper LMA; Berkhof J; Steenbergen RDM; Lissenberg-Witte BI; Snijders PJF; Meijer CJLM; Heideman DAM
Int J Cancer; 2018 Sep; 143(6):1541-1548. PubMed ID: 29663363
[TBL] [Abstract][Full Text] [Related]
31. [Cytological study of 191 women with invasive cancer of the uterine cervix in Brittany, France].
Lavoué V; Gautier C; Piette C; Porée P; Mesbah H; Foucher F; Vialard J; Levêque J
J Gynecol Obstet Biol Reprod (Paris); 2009 Sep; 38(5):396-403. PubMed ID: 19473783
[TBL] [Abstract][Full Text] [Related]
32. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer screening in immigrant women in Italy: a survey on participation, cytology and histology results.
Campari C; Fedato C; Iossa A; Petrelli A; Zorzi M; Anghinoni E; Bietta C; Brachini A; Brezzi S; Cogo C; Giordano L; Giorgi D; Palazzi M; Petrella M; Schivardi MR; Visioli CB; Giorgi Rossi P;
Eur J Cancer Prev; 2016 Jul; 25(4):321-8. PubMed ID: 26207563
[TBL] [Abstract][Full Text] [Related]
34. Detection of human papillomavirus in male and female urine by electrochemical DNA chip and PCR sequencing.
Nilyanimit P; Wanlapakorn N; Niruthisard S; Pohthipornthawat N; Karalak A; Laowahutanont P; Phanuphak N; Gemma N; Poovorawan Y
Asian Pac J Cancer Prev; 2013; 14(9):5519-25. PubMed ID: 24175852
[TBL] [Abstract][Full Text] [Related]
35. Cervical screening history in patients with early stage carcinoma of the cervix.
Abed Z; O'Leary M; Hand K; Flannelly G; Lenehan P; Murphy J; Foley M
Ir Med J; 2006 May; 99(5):140-2. PubMed ID: 16892918
[TBL] [Abstract][Full Text] [Related]
36. [Immigration from countries with a strong migratory pressure and participation in cervical cancer screening program in the Local Health Unit 2, Umbria Region. Impact on the probability of high-grade lesions and cervical cancer].
Vallesi G; Bietta C; Marri M; Petrella M
Epidemiol Prev; 2012; 36(2):95-9. PubMed ID: 22706359
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
[TBL] [Abstract][Full Text] [Related]
38. Papanicolaou smear history in women with low-grade cytology before cervical cancer diagnosis.
Bofin AM; Nygård JF; Skare GB; Dybdahl BM; Westerhagen U; Sauer T
Cancer; 2007 Aug; 111(4):210-6. PubMed ID: 17567833
[TBL] [Abstract][Full Text] [Related]
39. Cervical cancer: screening, diagnosis and staging.
Tsikouras P; Zervoudis S; Manav B; Tomara E; Iatrakis G; Romanidis C; Bothou A; Galazios G
J BUON; 2016; 21(2):320-5. PubMed ID: 27273940
[TBL] [Abstract][Full Text] [Related]
40. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
